Trimipramine

Trimipramine, sold under the brand name Surmontil among others, is a tricyclic antidepressant (TCA) which is used to treat depression. It has also been used for its sedative, anxiolytic, and weak antipsychotic effects in the treatment of insomnia, anxiety disorders, and psychosis, respectively. The drug is described as an atypical or "second-generation" TCA because, unlike other TCAs, it seems to be a fairly weak monoamine reuptake inhibitor. Similarly to other TCAs, however, trimipramine does have antihistamine, antiserotonergic, antiadrenergic, antidopaminergic, and anticholinergic activities.

Also known as: Trimipramine maleate, Surmontil

Classification

Chemical: Medicine
Psychoactive: Depressant
Tag: Antidepressant
Tag: Pharmaceutical
Tag: Tricyclic antidepressant

Effects

Sedation
Motor Impairment
Nausea
Headache
Anxiolysis
Insomnia
Reduced Anxiety
Dizziness
Euphoria
Anxiety Suppression
Anxiety
Mood Lift
Dulled Perception
Light Sensitivity
Sexual Dysfunction
Visual Acuity Suppression
Physical Enhancement
Dehydration

Routes of Administration

No route information available yet.

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu